Understanding Vitreous hemorrhage
Blood can enter the vitreous from abnormal fragile vessels, a damaged normal vessel or an adjacent bleeding site. Diabetes-related proliferative retinopathy, retinal vascular disorders, trauma and vitreous separation with a tear are important examples. The hemorrhage is a finding, not one single underlying disease. [1]
The amount and distribution of blood influence how much the view is affected, but long-term sight also depends on the retina underneath. Clearing the blood and treating the cause are separate goals. A clearer visual scene does not prove that an underlying vessel problem or retinal break has resolved. [2] [4]
One condition. Different experiences.
Explore different selected symptom features, then read how they may vary. These examples are not stages or a clinical test.
Original VisualSim schematic illustrations, informed by the cited clinical descriptions. These are not study figures, patient recordings or validated severity levels.
Moving dark material
Small spots, threads, webs or many new floaters may appear as blood disperses in the vitreous. These descriptions overlap with non-bleeding floaters, so symptoms alone cannot confirm hemorrhage. [1]
Haze or a dense loss of clarity
A small bleed can cause mild interference, while dense blood can markedly reduce vision. Color and density vary; not everyone sees a red-tinted curtain or a uniform black field. [1] [4]
Painless does not mean harmless
A hemorrhage may be painless even when a retinal tear or another serious source is present. Pain is also possible with associated pressure or injury, which needs its own assessment. [3] [4]
Identify the cause behind the obscured view
Original process schematic; no blood-clearance timer or substitute for a dilated retinal assessment. [1] [2] [5]
Original VisualSim teaching diagram · © VisualSim. Clinical basis in linked sources; not a published study figure. Image provenance.- Bleeding source
A vessel or adjacent source releases blood into the vitreous.
- Blocked view
Blood may interfere both with sight and the examiner’s retinal view.
- Two goals
Assessment and treatment address the hidden retina as well as clearing the media.
What is happening—and what remains uncertain
Vessels do not normally course through the clear vitreous gel. Bleeding can occur when traction disrupts a retinal vessel or when abnormal new vessels bleed, as in proliferative retinopathy. Trauma and other sources add different mechanisms, which is why treatment is not selected from appearance alone. [1] [2]
Blood blocks light transmission and can hide the retina from direct examination. Ultrasound helps investigate a dense hemorrhage, but evaluation may need to continue as the view changes or with additional examination; the management question includes the risk of a hidden retinal break. [2] [7]
What can look similar?
Blood in the vitreous versus a red surface patch
A subconjunctival hemorrhage is blood on the outer eye surface and usually has a different effect and assessment pathway. Vitreous hemorrhage is internal and cannot be identified from the visible white of the eye. [4]
Hemorrhage versus ordinary floaters
Vitreous opacities can occur without bleeding, but new symptoms need examination before being dismissed as benign floaters. A floater slider does not show the substance or cause. [1] [3]
Diabetic hemorrhage versus other sources
A trial about bleeding from proliferative diabetic retinopathy does not establish treatment for a traumatic bleed, retinal tear or tumor-associated hemorrhage. Identifying the source controls how research applies. [5]
Similar-looking symptoms can have different causes. A matching picture cannot establish a diagnosis.
What an assessment may involve
- History and a dilated retinal examinationReport onset, flashes, trauma, known retinal disease, diabetes and all medicines. The eye team assesses acuity, pressure and the visible retina while considering the fellow eye and systemic context. [1] [4]
- Investigate an obscured viewB-scan ultrasound can help detect detachment or other hidden pathology when blood blocks the retinal view. Dense hemorrhage with suspected vitreous separation can require close reassessment or surgery depending on risk; a single scan is not a blanket guarantee that no tear exists. [2] [7]
- Agree a concrete next stepAsk what cause is established, what remains uncertain and when the next examination will occur. Return sooner for worsening vision, a new shadow, pain or the team’s specified warning symptoms rather than waiting for all blood to clear. [2] [3]
What may help—and what is still being studied
Observation is a monitored option
Some bleeding can clear without surgery after appropriate assessment of the source and retinal risk. Observation should include a follow-up plan and management of the underlying disorder, not a generic instruction to wait several months regardless of cause. [1] [2]
Treat vessels or breaks when indicated
Depending on the cause, treatment may involve retinal laser, injections, repair of a tear or detachment, or another specific intervention. Anti-VEGF for proliferative diabetic bleeding is not a general cure for all hemorrhage and does not directly dissolve every blood clot. [1] [5]
Consider vitrectomy in context
Vitrectomy removes blood-filled gel and allows examination and treatment of the retina. Timing balances the possibility of spontaneous clearance against hidden pathology, functional disability and surgical risks such as cataract, infection or retinal detachment; evidence does not support one deadline for every source. [2] [6]
What this can mean for daily life
Plan around temporary reduced sight
Arrange help with transport or detailed tasks if vision is insufficient. Discuss work and home priorities with the team rather than using an eye-chart or simulator setting alone to decide safety. [8]
Ask about medicines rather than changing them yourself
Bring the full medication list, including anticoagulants, to the eye appointment and coordinate any proposed change with the prescriber. A bleeding-eye finding does not itself identify which medication, if any, should be changed. [4]
Keep the return plan visible
Store the urgent contact route and next review date in an accessible format. A reduction in floaters is useful to report, but it does not replace the planned examination of the underlying retina. [2] [3]
Prepare for procedure-specific restrictions
If surgery includes a gas bubble, obtain explicit advice about flying, altitude, positioning and nitrous-oxide anesthesia until the surgeon confirms the bubble is gone. These restrictions are not automatically the same for every hemorrhage or operation. [9]
Bring a clearer description to your appointment
Choose the questions you want to discuss. These choices stay in this page’s memory.
Research, with the context left in
Selected studies and guidance, with their populations and limitations. These are curated educational summaries, not a complete systematic review or a formal evidence rating.
DRCR Protocol AB: initial aflibercept versus vitrectomy with PRP
No statistically significant difference in the primary average-acuity outcome over 24 weeks; the confidence interval included a potentially important vitrectomy advantage. [5]
Limits and applicability: Not evidence of equivalence, and not applicable to every cause. Both groups could receive the alternative treatment during follow-up, complicating simple long-term treatment comparisons.
Early versus late vitrectomy in vitreous hemorrhage
Supports considering earlier surgery in selected eyes, particularly where underlying disease may progress or remain hidden. [6]
Limits and applicability: Heterogeneous causes, inconsistent early/late definitions and observational selection bias prevent a universal rule; delayed groups may exclude eyes that cleared without surgery.
Hemorrhagic posterior vitreous detachment scoping review
Highlights occult retinal-break risk and the possible value of early surgery in selected fundus-obscuring cases, while acknowledging similar visual outcomes in some comparisons. [2]
Limits and applicability: A scoping review of mixed evidence, not a new randomized comparison or a mandate to operate on every bleed. Source-specific risk estimates should not be generalized to all hemorrhage.
Questions researchers still need to answer
- Which examination and imaging features best identify people who benefit from early surgery for unexplained dense hemorrhage?
- How should speed of recovery, recurrence, treatment burden and long-term function be balanced for each underlying cause?
Trusted places to go next
Selected clinical references, research, practical support and ways to connect. Official pages checked 24 October 2026; each entry explains its scope and region.
ASRS — retinal patient glossary
Defines vitreous and hemorrhage terminology, with links to retinal conditions.
RNIB — support and community
Practical sight-loss advice and non-medical community connections during persistent impairment or recovery. This does not replace urgent retinal assessment.
Connections listed by the organization.
Diabetes UK — retinopathy support, when diabetes is the cause
Condition-specific diabetes eye information and routes to broader diabetes support. Relevant to diabetic retinopathy, not every vitreous bleed.
Moorfields — vitreoretinal emergency clinic information
Explains a specialist emergency service that assesses hemorrhage and retinal problems. The clinic is referral-only, not a walk-in or global emergency contact.
Questions you may still have
Does blood always look red in my vision?
No. People may notice dark floaters, webs, haze or reduced clarity. The perceived appearance does not establish the source or severity. [1]
If the blood clears, is the retina definitely fine?
No. The underlying cause and any hidden tear or vessel abnormality still require the agreed assessment and follow-up. [2] [3]
Do injections replace surgery for every bleed?
No. Evidence such as Protocol AB concerns a defined diabetic population. A retinal tear, detachment, trauma or another source may require a different approach. [5]
Sources, image credits and review status
Compiled by VisualSim from clinical references and published research. Sources checked 24 October 2026. Independent clinical review has not been recorded; no named clinical reviewer or clinical validation is claimed. Research evidence and its limitations are linked below.
- Shaikh et al. — Vitreous hemorrhage: Causes, diagnosis, and management (2023; review).
Indexed original clinical body checked; direct PMC challenge. Laboratory investigations are tailored, not the broad universal panel found in another general chapter.
Checked 2026-10-24 · Full text checked - Hemorrhagic posterior vitreous detachment: A comprehensive review (2026; review).
Original indexed abstract and highlights read; direct publisher 403. Online September 17, 2026; scoping review, not randomized trial.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - NEI — Retinal detachment (n.d.; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked - StatPearls — Vitreous Hemorrhage (2023; review).
Indexed original clinical chapter checked; actual update August 25, 2023. Clinical context and medication history retained without self-adjustment instructions.
Checked 2026-10-24 · Full text checked - Antoszyk et al. — Aflibercept versus vitrectomy with PRP: Protocol AB (2020; trial).
Indexed original methods and results read. PDR-only population, 24-week primary outcome, confidence interval and crossover retained.
Checked 2026-10-24 · Full text checked - Early versus Late Pars Plana Vitrectomy in Vitreous Hemorrhage: A Systematic Review (2023; systematic review).
Indexed original discussion and limitations read; direct PMC challenge. Selection bias and inconsistent timing definitions explicit.
Checked 2026-10-24 · Full text checked - Safety profile and surgical outcomes of early vitrectomy in unexplained fundus-obscuring hemorrhage (2023; observational).
Selected retrospective 186-eye surgical cohort, not general-population risk or proof of universal superiority.
Checked 2026-10-24 · Abstract/indexed material checked; complete full-text review not claimed - RNIB — support and community (n.d.; institution).
Relevant page content and scope checked; source verification is not independent clinical review.
Checked 2026-10-24 · Public page checked - RNIB/RCOphth — Understanding retinal detachment (2023; institution).
Publication date 2023 despite 2026 hosting path. Gas restrictions apply only where a bubble is present.
Checked 2026-10-24 · Public page checked - NHS — Vision loss (n.d.; institution).
Official sudden sight-loss/severe pain emergency versus other urgent visual-change guidance checked; local service routes vary internationally.
Checked 2026-10-24 · Public page checked
The simulator helps people communicate an experience. It cannot diagnose a condition, measure a visual field, or establish that someone is safe to drive.